Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Bayani

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|November 15, 2023
Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrenceWilliam Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
Cancers|April 27, 2024
Investigating the Role of <i>SNAI1</i> and <i>ZEB1</i> Expression in Prostate Cancer Progression and Immune Modulation of the Tumor MicroenvironmentWilliam Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves, et al.
Plos One|October 1, 2021
Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumoursJohn Bartlett, Yutaka Amemiya, Heleen Arts, et al.
Cancers|May 27, 2026
Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active SurveillanceSoo Jin Seung, Jane Bayani, Lena Nguyen, et al.
BMC Cancer|April 20, 2023
The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER)Lucas C Mendez, Aneesh Dhar, David Laidley, et al.
The Prostate|May 3, 2026
Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate CancerWilliam Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2005
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor lineYuwei Wang, Hui Xue, Jean-Claude Cutz, et al.
JCO Precision Oncology|February 1, 2022
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast CancersJane Bayani, Elizabeth N Kornaga, Cheryl Crozier, et al.
Breast Cancer Research : BCR|October 7, 2025
Genomic landscape of cancer driver genes in Omani breast cancers: a pilot studyMuna Al Dlali, Buthaina Al Amri, Noura Al Zeheimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM TrialJohn M S Bartlett, Keying Xu, Jenna Wong, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|November 15, 2023
Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrenceWilliam Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
Cancers|April 27, 2024
Investigating the Role of <i>SNAI1</i> and <i>ZEB1</i> Expression in Prostate Cancer Progression and Immune Modulation of the Tumor MicroenvironmentWilliam Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves, et al.
Plos One|October 1, 2021
Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumoursJohn Bartlett, Yutaka Amemiya, Heleen Arts, et al.
Cancers|May 27, 2026
Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active SurveillanceSoo Jin Seung, Jane Bayani, Lena Nguyen, et al.
BMC Cancer|April 20, 2023
The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER)Lucas C Mendez, Aneesh Dhar, David Laidley, et al.
The Prostate|May 3, 2026
Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate CancerWilliam Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2005
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor lineYuwei Wang, Hui Xue, Jean-Claude Cutz, et al.
JCO Precision Oncology|February 1, 2022
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast CancersJane Bayani, Elizabeth N Kornaga, Cheryl Crozier, et al.
Breast Cancer Research : BCR|October 7, 2025
Genomic landscape of cancer driver genes in Omani breast cancers: a pilot studyMuna Al Dlali, Buthaina Al Amri, Noura Al Zeheimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM TrialJohn M S Bartlett, Keying Xu, Jenna Wong, et al.
Pageof 9